MP12-09 THE MAN VAN: COMMUNITY BASED TARGETED CASE FINDING FOR PROSTATE CANCER

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP12-09 THE MAN VAN: COMMUNITY BASED TARGETED CASE FINDING FOR PROSTATE CANCER Masood Moghul, Fionnuala Croft, Kaljit Kaur, Netty Kinsella, Declan Cahill, and Nicholas James Masood MoghulMasood Moghul More articles by this author , Fionnuala CroftFionnuala Croft More articles by this author , Kaljit KaurKaljit Kaur More articles by this author , Netty KinsellaNetty Kinsella More articles by this author , Declan CahillDeclan Cahill More articles by this author , and Nicholas JamesNicholas James More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003227.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Early intervention is potentially lifesaving in prostate cancer however barriers to early access remain. The Man Van project is designed to address these with a highly novel community-based targeting of high-risk groups on a mobile unit. METHODS: A bespoke mobile health vehicle was moved to 7 different community-based locations in areas of high deprivation indices in London, inviting men for a health check consisting of: health questionnaires, blood pressure, height/weight, HbA1c for diabetes and a PSA test where relevant. Telemedicine techniques were used to inform patients of outcomes. Direct referrals to secondary care were used if needed. Community engagement to increase uptake was performed using various methods including: primary care centres, religious organisations and community centres. RESULTS: Between December 2021 and September 2022, 444 men were seen at Man Van clinics (non-attendance rate 26%). The highest uptake was in the primary care centre. The median age of attendees was 55 years, range 25-87. 42% of attendees were non-white (30% black). The median BMI was 27.7, range 16.2-50.5. 298 PSA tests were performed with 10 prostate cancers (3.4%) found till date. 6 (60%) of these cancers were grade group 2 (all >5% pattern 4). Of patients diagnosed with prostate cancer the median age was 54 years, range 48-73, 70% were black, median PSA 5.2 μg/L, range 0.81-9.4, median IPSS score was 9.5, range 2-31, median IIEF-5 was 16, range 1-25. 1 bladder and 1 oesophageal cancer were also found. 239 HbA1c tests were performed with 14 diabetics diagnosed (5.9%). 26 patients (5.9%) required input for benign urinary symptoms and 12 for erectile dysfunction (2.7%). Primary care referrals: 98 for hypertension (22.1%), 41 for elevated BMI (9.2%), 36 for mental health issues (8.1%). Of 138 patients at risk for excess alcohol intake, 40 were referred (29%), of 62 smokers 45 were referred for smoking cessation (72.6%). Significantly more patients ≥45 years were referred for primary care follow-up versus <45 years (P<0.05). Service evaluation questionnaires showed overwhelmingly positive support for the service. CONCLUSIONS: The Man Van initiative is a novel method of linking primary and secondary care for a range of men’s health checks, including PSA. By improving community awareness and access in high-risk groups we demonstrate high uptakes for health checks including for prostate cancer and a willingness to engage with health improvement measures. Source of Funding: NHS England grant © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e136 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Masood Moghul More articles by this author Fionnuala Croft More articles by this author Kaljit Kaur More articles by this author Netty Kinsella More articles by this author Declan Cahill More articles by this author Nicholas James More articles by this author Expand All Advertisement PDF downloadLoading ...